Type 2 diabetes trials in France

In France 45 Also abroad 1200

45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in France
Immunological Signatures of MASLD and MASH in Patients With Type 1 Diabetes
Where
Paris
Age
18 years and over
People
1,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07927647
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Angers, Bois-Guillaume, Dijon, Paris, Pessac Cedex, Pierre-Bénite, Poitiers, Saint-Herblain
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Lyon, Marseille, Nice, Paris Cedex 15, Tours Cedex 9
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Bron, Paris
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
No phaseTaking people
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Where
Paris
Age
18 years and over
People
165
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07604922
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Montpellier, Paris, Saint-Herblain
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Not yet taking people in France
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Corbeil Essonnes Cedex, La Tronche, Le Coudray, Nantes, Nantes Cedex 1, Paris, Pierre-Bénite, Poitiers, Rouen, Toulouse cedex 9, Vénissieux
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bobigny, Colmar Cedex, Dijon, Lyon, Paris, Pessac, Pierre-Bénite, Thionville, Toulouse Cedex 9, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Besancon Cedex, Boulogne-Billancourt, Brest, Bron, Caen Cedex 9, Chalon Sur Saone Cedex, Chambéry, Chambray Les Tours, Corbeil-Essonnes, Évecquemont, Grenoble, Grenoble Cedex 9, Haguenau, Jossigny, La Rochelle, Le Chesnay Rocquencourt, Le Coudray, Lille, Lyon, Marseille, Meaux, Metz Cedex 03, Montpellier, Nice, Paris, Paris Cedex 18, Pau, Pessac Cedex, Poitiers, Quimper Cedex, Reims Cedex, Saint-Brieuc, Saint-Herblain, Strasbourg, Toulouse Cedex 9, Troyes, Vandoeuvre Les Nancy, Vénissieux
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
No phaseTaking people
Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors.
Where
Nice
Age
18 years and over
People
290
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07392437
Phase 3Taking people
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Where
Bordeaux, Paris
Age
18 years and over
People
220 worldwide
Run by
Khondrion BV
See details and how to joinNCT06451757
No phaseTaking people
Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
Where
Villeurbanne
Age
18 years to 65 years
People
30
Run by
Médipôle Lyon-Villeurbanne
See details and how to joinNCT06600555
Phase 3Taking people
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Where
Barbâtre, Béziers, Bezouces, Bron, Caen, Carcassonne, Granville, Grenoble Cedex 9, Joze, La Courneuve, Le Grand-Quevilly, Le Havre, Luc-La-Primaube, Marseille, Montauban, Montigny-Le-Bretonneux, Montpellier, Montpellier Cedex 5, Morsang-sur-Orge, Nimes Cedex 9, Pantin, Paris 19, Pau, Pins-Justaret, Poissy, Poitiers, Pontgibaud, Pornic, Saint-Herblain, Sète, Toulouse, Toulouse Cedex 9, Vannes, Vergèze
Age
55 years to 80 years
People
10,000 worldwide
Run by
Montreal Heart Institute
See details and how to joinNCT05633810 · EU 2024-516646-19-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Bois-Guillaume, Colmar Cedex, Le Coudray, Paris, Pessac, Pierre-Bénite, Saint-Herblain, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Paris
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
Phase 2Taking people
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
Where
Paris, Paris Cedex 13
Age
16 years to 45 years
People
24
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05153070 · EU 2024-514043-29-00
No phaseTaking people
Early Detection of Type 1 Diabetes
Where
Bron
Age
1 year to 18 years
People
106
Run by
Hospices Civils de Lyon
See details and how to joinNCT06984185
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Lille Cedex, Strasbourg Cedex 2
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Angers, Bobigny, Bondy, Corbeil-Essonnes, Lyon, Nice, Paris, Vandœuvre-lès-Nancy
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
No phaseNot yet taking people in France
Evaluation of the Effectiveness of Extending the "Passerelle" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)
Where
Bergerac
Age
18 years and over
People
308
Run by
University Hospital, Bordeaux
See details and how to joinNCT06493955
No phaseTaking people
Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing.
Where
Dijon
Age
18 years to 18 years
People
308
Run by
Centre Hospitalier Universitaire Dijon
See details and how to joinNCT06630182
No phaseTaking people
Insulin Pump Versus Full Closed-loop for Type 2 Diabetes
Where
Caen
Age
18 years and over
People
80
Run by
University Hospital, Caen
See details and how to joinNCT06959797
No phaseTaking people
Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air
Where
Salies-du-Salat, Toulouse
Age
18 years and over
People
235
Run by
University Hospital, Toulouse
See details and how to joinNCT06614101
No phaseNot yet taking people in France
Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes
Where
Toulouse
Age
45 years to 70 years
People
45
Run by
University Hospital, Toulouse
See details and how to joinNCT07075133
No phaseTaking people
Collection of Human Metabolic Tissues
Where
Montpellier
Age
18 years to 65 years
People
270
Run by
University Hospital, Montpellier
See details and how to joinNCT02861781